Claudia Biehl

De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial

Nadia Harbeck, Ulrike Nitz, Matthias Christgen et al. · Journal of Clinical Oncology · 2023 · 33 citations

Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer

Nadia Harbeck, Raquel von Schumann, Ronald Kates et al. · Cancers · 2021 · 17 citations · Full text

Patient participation in multidisciplinary tumor conferences: How is it implemented? What is the patients’ role? What are patients’ experiences?

Lena Ansmann, Christian Heuser, Annika Diekmann et al. · Cancer Medicine · 2021 · 14 citations · Full text

Interstitial loss and gain of sequences on chromosome 22 in meningiomas with normal karyotype

Alexandra Prowald, Silke Wemmert, Claudia Biehl et al. · International Journal of Oncology · 2005 · 13 citations

Chromatin, Developmental Biology, Chromosome Aberration +11

Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial

Monika Graeser, Oleg Gluz, Claudia Biehl et al. · Clinical Cancer Research · 2022 · 13 citations · Full text